Share Price and Basic Stock Data
Last Updated: November 19, 2025, 10:37 pm
| PEG Ratio | -6.40 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Sree Rayalaseema Hi-Strength Hypo Ltd operates in the chemicals sector, specifically focusing on inorganic chemicals. As of the latest reported period, the company’s stock price stood at ₹533 with a market capitalization of ₹919 Cr. The company has witnessed significant revenue fluctuations over recent quarters. Sales recorded for the financial year ending March 2023 reached ₹1,650 Cr, a notable increase from ₹1,267 Cr in the previous year. However, sales for the trailing twelve months (TTM) have shown a decline, standing at ₹649 Cr, indicating a potential downturn in market demand. Quarterly sales figures have also exhibited a downward trend, with the most recent quarter (Sep 2023) reporting revenues of ₹226 Cr, down from ₹570 Cr in Jun 2022. This inconsistency in revenue performance raises concerns about the company’s ability to maintain growth in a competitive landscape.
Profitability and Efficiency Metrics
Profitability metrics for Sree Rayalaseema Hi-Strength Hypo Ltd reveal an operating profit margin (OPM) of 16% as of the latest report, reflecting the company’s operational efficiency. However, OPM has varied significantly, peaking at 15% in Mar 2023 but declining to 12% by Sep 2023. The net profit for the financial year ending March 2023 was recorded at ₹154 Cr, translating to an earnings per share (EPS) of ₹89.90. Notably, the company reported a return on equity (ROE) of 11% and a return on capital employed (ROCE) of 14.9%, which are relatively competitive figures in the chemicals sector. The interest coverage ratio (ICR) stood impressively at 66.46x, indicating a strong ability to meet interest obligations. However, the drop in net profit to ₹93 Cr for the financial year ending March 2025, alongside declining quarterly profits, raises questions about sustained profitability.
Balance Sheet Strength and Financial Ratios
The balance sheet of Sree Rayalaseema Hi-Strength Hypo Ltd reflects a robust financial position with total reserves amounting to ₹905 Cr and minimal borrowings of ₹15 Cr. The company maintains a current ratio of 8.99, significantly above the typical sector benchmark, indicating excellent liquidity. Furthermore, the company has a low total debt-to-equity ratio of 0.00, demonstrating a conservative approach to leveraging. The price-to-book value ratio is reported at 0.92x, suggesting that the stock is trading below its book value, which could be attractive for value investors. However, the company’s cash conversion cycle (CCC) has increased to 90 days, indicating potential inefficiencies in managing working capital. This extended cycle could hinder liquidity and operational agility, particularly in a volatile market environment.
Shareholding Pattern and Investor Confidence
The shareholding structure of Sree Rayalaseema Hi-Strength Hypo Ltd indicates a strong promoter backing, with promoters holding 61.84% as of Mar 2025. This substantial stake provides a sense of stability and confidence for investors. Institutional investment remains minimal, with foreign institutional investors (FIIs) at 0.14% and domestic institutional investors (DIIs) at 0.05%. The public holds 38.05%, reflecting a diverse shareholder base with 43,085 total shareholders. The decline in the number of shareholders from 64,522 in Dec 2022 to 43,085 in Mar 2025 may signal waning investor interest or confidence. The low levels of institutional investment could also impact the stock’s liquidity and perceived stability, affecting overall investor sentiment.
Outlook, Risks, and Final Insight
Looking ahead, Sree Rayalaseema Hi-Strength Hypo Ltd faces both opportunities and challenges. The company’s strong balance sheet and high interest coverage ratio suggest resilience; however, the declining revenue and profitability trends could pose significant risks. Operational inefficiencies, as indicated by the rising cash conversion cycle, may further strain financial performance. The lack of institutional backing could hinder stock performance in turbulent market conditions. To enhance growth, the company may need to optimize operations and explore new market opportunities. Additionally, increasing promoter stakes could be a double-edged sword, offering stability but potentially limiting broader investor participation. Ultimately, the company must navigate these challenges carefully to unlock its full potential and deliver sustainable shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Sree Rayalaseema Hi-Strength Hypo Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 2,924 Cr. | 45.2 | 125/45.2 | 146 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 15.9 Cr. | 31.8 | 48.3/25.8 | 69.1 | 16.0 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 208 Cr. | 266 | 410/238 | 12.4 | 211 | 3.01 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 6,952 Cr. | 564 | 730/408 | 33.9 | 157 | 0.53 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 346 Cr. | 443 | 536/376 | 16.9 | 144 | 0.68 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 5,033.38 Cr | 573.00 | 172.09 | 160.00 | 0.49% | 13.95% | 10.65% | 7.00 |
All Competitor Stocks of Sree Rayalaseema Hi-Strength Hypo Ltd
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 570 | 344 | 301 | 435 | 261 | 226 | 215 | 165 | 169 | 170 | 138 | 160 | 180 |
| Expenses | 517 | 310 | 274 | 371 | 226 | 199 | 192 | 138 | 142 | 140 | 117 | 143 | 152 |
| Operating Profit | 53 | 34 | 26 | 64 | 35 | 26 | 22 | 27 | 27 | 30 | 21 | 18 | 28 |
| OPM % | 9% | 10% | 9% | 15% | 13% | 12% | 10% | 16% | 16% | 18% | 15% | 11% | 16% |
| Other Income | 0 | 3 | 11 | 20 | 1 | 2 | 4 | 5 | 3 | 9 | 13 | 12 | 6 |
| Interest | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 0 | 0 | 0 | 1 | 0 |
| Depreciation | 4 | 5 | 5 | 5 | 3 | 3 | 3 | 3 | 1 | 2 | 1 | 1 | 1 |
| Profit before tax | 49 | 31 | 32 | 79 | 33 | 25 | 23 | 27 | 28 | 36 | 32 | 28 | 32 |
| Tax % | 26% | 24% | 26% | 9% | 26% | 27% | 29% | 23% | 26% | 29% | 27% | 19% | 28% |
| Net Profit | 36 | 24 | 24 | 71 | 24 | 18 | 17 | 21 | 20 | 26 | 24 | 23 | 23 |
| EPS in Rs | 20.94 | 13.79 | 13.72 | 41.45 | 14.17 | 10.78 | 9.69 | 12.22 | 11.94 | 15.12 | 13.71 | 13.23 | 13.64 |
Last Updated: August 20, 2025, 3:10 am
Below is a detailed analysis of the quarterly data for Sree Rayalaseema Hi-Strength Hypo Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 180.00 Cr.. The value appears strong and on an upward trend. It has increased from 160.00 Cr. (Mar 2025) to 180.00 Cr., marking an increase of 20.00 Cr..
- For Expenses, as of Jun 2025, the value is 152.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 143.00 Cr. (Mar 2025) to 152.00 Cr., marking an increase of 9.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 18.00 Cr. (Mar 2025) to 28.00 Cr., marking an increase of 10.00 Cr..
- For OPM %, as of Jun 2025, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 11.00% (Mar 2025) to 16.00%, marking an increase of 5.00%.
- For Other Income, as of Jun 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 6.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 32.00 Cr.. The value appears strong and on an upward trend. It has increased from 28.00 Cr. (Mar 2025) to 32.00 Cr., marking an increase of 4.00 Cr..
- For Tax %, as of Jun 2025, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from 19.00% (Mar 2025) to 28.00%, marking an increase of 9.00%.
- For Net Profit, as of Jun 2025, the value is 23.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 23.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 13.64. The value appears strong and on an upward trend. It has increased from 13.23 (Mar 2025) to 13.64, marking an increase of 0.41.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:23 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 295 | 392 | 362 | 366 | 546 | 702 | 689 | 911 | 1,267 | 1,650 | 866 | 638 | 649 |
| Expenses | 262 | 351 | 318 | 317 | 500 | 604 | 587 | 781 | 1,119 | 1,470 | 755 | 542 | 552 |
| Operating Profit | 33 | 41 | 44 | 50 | 46 | 98 | 102 | 130 | 149 | 180 | 111 | 96 | 98 |
| OPM % | 11% | 10% | 12% | 14% | 8% | 14% | 15% | 14% | 12% | 11% | 13% | 15% | 15% |
| Other Income | 9 | 9 | 2 | -2 | 19 | 5 | 4 | 7 | 11 | 34 | 13 | 36 | 39 |
| Interest | 16 | 14 | 11 | 8 | 9 | 16 | 10 | 5 | 3 | 5 | 4 | 2 | 2 |
| Depreciation | 15 | 10 | 10 | 25 | 19 | 45 | 50 | 51 | 19 | 19 | 11 | 6 | 6 |
| Profit before tax | 12 | 26 | 26 | 15 | 37 | 42 | 45 | 81 | 137 | 190 | 109 | 124 | 129 |
| Tax % | 36% | 25% | 27% | -27% | 1% | 52% | 17% | 25% | 25% | 19% | 26% | 25% | |
| Net Profit | 7 | 19 | 19 | 18 | 37 | 20 | 38 | 61 | 103 | 154 | 80 | 93 | 96 |
| EPS in Rs | 5.06 | 13.16 | 12.72 | 11.86 | 22.45 | 11.90 | 22.09 | 35.30 | 59.88 | 89.90 | 46.85 | 53.99 | 55.70 |
| Dividend Payout % | 0% | 11% | 12% | 13% | 9% | 17% | 11% | 8% | 6% | 4% | 6% | 6% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 171.43% | 0.00% | -5.26% | 105.56% | -45.95% | 90.00% | 60.53% | 68.85% | 49.51% | -48.05% | 16.25% |
| Change in YoY Net Profit Growth (%) | 0.00% | -171.43% | -5.26% | 110.82% | -151.50% | 135.95% | -29.47% | 8.33% | -19.34% | -97.57% | 64.30% |
Sree Rayalaseema Hi-Strength Hypo Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | -2% |
| 3 Years: | -20% |
| TTM: | -16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 20% |
| 3 Years: | -3% |
| TTM: | 20% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 30% |
| 3 Years: | -7% |
| 1 Year: | 4% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 16% |
| 3 Years: | 14% |
| Last Year: | 11% |
Last Updated: September 5, 2025, 1:36 pm
Balance Sheet
Last Updated: October 10, 2025, 3:00 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15 | 15 | 15 | 15 | 16 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves | 135 | 157 | 173 | 222 | 302 | 308 | 294 | 371 | 553 | 734 | 785 | 905 |
| Borrowings | 88 | 87 | 85 | 55 | 78 | 52 | 57 | 72 | 28 | 16 | 5 | 15 |
| Other Liabilities | 130 | 99 | 84 | 60 | 64 | 93 | 76 | 59 | 189 | 174 | 100 | 121 |
| Total Liabilities | 367 | 358 | 357 | 352 | 460 | 470 | 445 | 519 | 787 | 941 | 907 | 1,059 |
| Fixed Assets | 200 | 194 | 195 | 182 | 194 | 194 | 161 | 134 | 130 | 105 | 103 | 112 |
| CWIP | 0 | 5 | 2 | 8 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 |
| Investments | 32 | 23 | 23 | 43 | 105 | 65 | 18 | 50 | 164 | 268 | 253 | 366 |
| Other Assets | 135 | 136 | 137 | 118 | 161 | 210 | 262 | 334 | 494 | 568 | 551 | 580 |
| Total Assets | 367 | 358 | 357 | 352 | 460 | 470 | 445 | 519 | 787 | 941 | 907 | 1,059 |
Below is a detailed analysis of the balance sheet data for Sree Rayalaseema Hi-Strength Hypo Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 17.00 Cr..
- For Reserves, as of Mar 2025, the value is 905.00 Cr.. The value appears strong and on an upward trend. It has increased from 785.00 Cr. (Mar 2024) to 905.00 Cr., marking an increase of 120.00 Cr..
- For Borrowings, as of Mar 2025, the value is 15.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 5.00 Cr. (Mar 2024) to 15.00 Cr., marking an increase of 10.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 121.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 100.00 Cr. (Mar 2024) to 121.00 Cr., marking an increase of 21.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,059.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 907.00 Cr. (Mar 2024) to 1,059.00 Cr., marking an increase of 152.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 112.00 Cr.. The value appears strong and on an upward trend. It has increased from 103.00 Cr. (Mar 2024) to 112.00 Cr., marking an increase of 9.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 366.00 Cr.. The value appears strong and on an upward trend. It has increased from 253.00 Cr. (Mar 2024) to 366.00 Cr., marking an increase of 113.00 Cr..
- For Other Assets, as of Mar 2025, the value is 580.00 Cr.. The value appears strong and on an upward trend. It has increased from 551.00 Cr. (Mar 2024) to 580.00 Cr., marking an increase of 29.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,059.00 Cr.. The value appears strong and on an upward trend. It has increased from 907.00 Cr. (Mar 2024) to 1,059.00 Cr., marking an increase of 152.00 Cr..
Notably, the Reserves (905.00 Cr.) exceed the Borrowings (15.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -55.00 | -46.00 | -41.00 | -5.00 | -32.00 | 46.00 | 45.00 | 58.00 | 121.00 | 164.00 | 106.00 | 81.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 33 | 33 | 54 | 30 | 38 | 46 | 43 | 39 | 38 | 33 | 45 | 59 |
| Inventory Days | 67 | 42 | 37 | 55 | 34 | 34 | 36 | 27 | 62 | 39 | 24 | 49 |
| Days Payable | 97 | 79 | 39 | 66 | 21 | 38 | 24 | 8 | 33 | 22 | 10 | 18 |
| Cash Conversion Cycle | 3 | -4 | 51 | 19 | 51 | 41 | 55 | 57 | 67 | 50 | 59 | 90 |
| Working Capital Days | -23 | -15 | 1 | 12 | 16 | 32 | 24 | 23 | 47 | 45 | 67 | 79 |
| ROCE % | 11% | 13% | 14% | 9% | 9% | 14% | 15% | 21% | 26% | 26% | 16% | 15% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 52.47 | 46.01 | 89.97 | 59.88 | 35.29 |
| Diluted EPS (Rs.) | 52.47 | 46.01 | 89.97 | 59.88 | 35.29 |
| Cash EPS (Rs.) | 55.22 | 52.18 | 101.14 | 71.08 | 64.77 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 534.98 | 466.47 | 437.58 | 332.26 | 226.03 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 534.98 | 466.47 | 437.58 | 332.26 | 226.03 |
| Revenue From Operations / Share (Rs.) | 371.59 | 504.53 | 961.34 | 738.30 | 530.63 |
| PBDIT / Share (Rs.) | 76.62 | 77.32 | 124.97 | 92.87 | 79.77 |
| PBIT / Share (Rs.) | 72.35 | 71.14 | 113.70 | 81.67 | 50.29 |
| PBT / Share (Rs.) | 69.42 | 62.50 | 110.93 | 79.80 | 47.10 |
| Net Profit / Share (Rs.) | 50.96 | 46.01 | 89.87 | 59.88 | 35.29 |
| NP After MI And SOA / Share (Rs.) | 52.47 | 46.01 | 89.87 | 59.88 | 35.29 |
| PBDIT Margin (%) | 20.61 | 15.32 | 12.99 | 12.57 | 15.03 |
| PBIT Margin (%) | 19.47 | 14.10 | 11.82 | 11.06 | 9.47 |
| PBT Margin (%) | 18.68 | 12.38 | 11.53 | 10.80 | 8.87 |
| Net Profit Margin (%) | 13.71 | 9.11 | 9.34 | 8.11 | 6.65 |
| NP After MI And SOA Margin (%) | 14.12 | 9.11 | 9.34 | 8.11 | 6.65 |
| Return on Networth / Equity (%) | 9.80 | 9.86 | 20.54 | 18.02 | 15.61 |
| Return on Capital Employeed (%) | 12.35 | 14.20 | 25.52 | 24.05 | 21.55 |
| Return On Assets (%) | 8.42 | 8.64 | 17.18 | 13.04 | 11.67 |
| Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.00 | 0.01 | 0.01 | 0.03 | 0.15 |
| Asset Turnover Ratio (%) | 0.64 | 0.95 | 1.96 | 1.94 | 1.89 |
| Current Ratio (X) | 8.99 | 9.75 | 4.17 | 2.35 | 2.65 |
| Quick Ratio (X) | 8.38 | 9.17 | 3.22 | 1.65 | 2.32 |
| Inventory Turnover Ratio (X) | 17.86 | 5.03 | 4.24 | 5.39 | 9.03 |
| Dividend Payout Ratio (NP) (%) | 5.71 | 8.69 | 3.89 | 5.01 | 7.08 |
| Dividend Payout Ratio (CP) (%) | 5.28 | 7.66 | 3.46 | 4.22 | 3.86 |
| Earning Retention Ratio (%) | 94.29 | 91.31 | 96.11 | 94.99 | 92.92 |
| Cash Earning Retention Ratio (%) | 94.72 | 92.34 | 96.54 | 95.78 | 96.14 |
| Interest Coverage Ratio (X) | 66.46 | 33.31 | 45.16 | 49.69 | 25.01 |
| Interest Coverage Ratio (Post Tax) (X) | 46.75 | 23.54 | 33.48 | 33.04 | 12.06 |
| Enterprise Value (Cr.) | 487.59 | 518.25 | 489.04 | 718.64 | 328.19 |
| EV / Net Operating Revenue (X) | 0.76 | 0.59 | 0.29 | 0.56 | 0.36 |
| EV / EBITDA (X) | 3.71 | 3.90 | 2.28 | 4.51 | 2.40 |
| MarketCap / Net Operating Revenue (X) | 1.33 | 0.97 | 0.42 | 0.64 | 0.44 |
| Retention Ratios (%) | 94.28 | 91.30 | 96.10 | 94.98 | 92.91 |
| Price / BV (X) | 0.92 | 1.05 | 0.94 | 1.43 | 1.05 |
| Price / Net Operating Revenue (X) | 1.33 | 0.97 | 0.42 | 0.64 | 0.44 |
| EarningsYield | 0.10 | 0.09 | 0.21 | 0.12 | 0.14 |
After reviewing the key financial ratios for Sree Rayalaseema Hi-Strength Hypo Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 52.47. This value is within the healthy range. It has increased from 46.01 (Mar 24) to 52.47, marking an increase of 6.46.
- For Diluted EPS (Rs.), as of Mar 25, the value is 52.47. This value is within the healthy range. It has increased from 46.01 (Mar 24) to 52.47, marking an increase of 6.46.
- For Cash EPS (Rs.), as of Mar 25, the value is 55.22. This value is within the healthy range. It has increased from 52.18 (Mar 24) to 55.22, marking an increase of 3.04.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 534.98. It has increased from 466.47 (Mar 24) to 534.98, marking an increase of 68.51.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 534.98. It has increased from 466.47 (Mar 24) to 534.98, marking an increase of 68.51.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 371.59. It has decreased from 504.53 (Mar 24) to 371.59, marking a decrease of 132.94.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 76.62. This value is within the healthy range. It has decreased from 77.32 (Mar 24) to 76.62, marking a decrease of 0.70.
- For PBIT / Share (Rs.), as of Mar 25, the value is 72.35. This value is within the healthy range. It has increased from 71.14 (Mar 24) to 72.35, marking an increase of 1.21.
- For PBT / Share (Rs.), as of Mar 25, the value is 69.42. This value is within the healthy range. It has increased from 62.50 (Mar 24) to 69.42, marking an increase of 6.92.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 50.96. This value is within the healthy range. It has increased from 46.01 (Mar 24) to 50.96, marking an increase of 4.95.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 52.47. This value is within the healthy range. It has increased from 46.01 (Mar 24) to 52.47, marking an increase of 6.46.
- For PBDIT Margin (%), as of Mar 25, the value is 20.61. This value is within the healthy range. It has increased from 15.32 (Mar 24) to 20.61, marking an increase of 5.29.
- For PBIT Margin (%), as of Mar 25, the value is 19.47. This value is within the healthy range. It has increased from 14.10 (Mar 24) to 19.47, marking an increase of 5.37.
- For PBT Margin (%), as of Mar 25, the value is 18.68. This value is within the healthy range. It has increased from 12.38 (Mar 24) to 18.68, marking an increase of 6.30.
- For Net Profit Margin (%), as of Mar 25, the value is 13.71. This value exceeds the healthy maximum of 10. It has increased from 9.11 (Mar 24) to 13.71, marking an increase of 4.60.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 14.12. This value is within the healthy range. It has increased from 9.11 (Mar 24) to 14.12, marking an increase of 5.01.
- For Return on Networth / Equity (%), as of Mar 25, the value is 9.80. This value is below the healthy minimum of 15. It has decreased from 9.86 (Mar 24) to 9.80, marking a decrease of 0.06.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.35. This value is within the healthy range. It has decreased from 14.20 (Mar 24) to 12.35, marking a decrease of 1.85.
- For Return On Assets (%), as of Mar 25, the value is 8.42. This value is within the healthy range. It has decreased from 8.64 (Mar 24) to 8.42, marking a decrease of 0.22.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.64. It has decreased from 0.95 (Mar 24) to 0.64, marking a decrease of 0.31.
- For Current Ratio (X), as of Mar 25, the value is 8.99. This value exceeds the healthy maximum of 3. It has decreased from 9.75 (Mar 24) to 8.99, marking a decrease of 0.76.
- For Quick Ratio (X), as of Mar 25, the value is 8.38. This value exceeds the healthy maximum of 2. It has decreased from 9.17 (Mar 24) to 8.38, marking a decrease of 0.79.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 17.86. This value exceeds the healthy maximum of 8. It has increased from 5.03 (Mar 24) to 17.86, marking an increase of 12.83.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 5.71. This value is below the healthy minimum of 20. It has decreased from 8.69 (Mar 24) to 5.71, marking a decrease of 2.98.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.28. This value is below the healthy minimum of 20. It has decreased from 7.66 (Mar 24) to 5.28, marking a decrease of 2.38.
- For Earning Retention Ratio (%), as of Mar 25, the value is 94.29. This value exceeds the healthy maximum of 70. It has increased from 91.31 (Mar 24) to 94.29, marking an increase of 2.98.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.72. This value exceeds the healthy maximum of 70. It has increased from 92.34 (Mar 24) to 94.72, marking an increase of 2.38.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 66.46. This value is within the healthy range. It has increased from 33.31 (Mar 24) to 66.46, marking an increase of 33.15.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 46.75. This value is within the healthy range. It has increased from 23.54 (Mar 24) to 46.75, marking an increase of 23.21.
- For Enterprise Value (Cr.), as of Mar 25, the value is 487.59. It has decreased from 518.25 (Mar 24) to 487.59, marking a decrease of 30.66.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1. It has increased from 0.59 (Mar 24) to 0.76, marking an increase of 0.17.
- For EV / EBITDA (X), as of Mar 25, the value is 3.71. This value is below the healthy minimum of 5. It has decreased from 3.90 (Mar 24) to 3.71, marking a decrease of 0.19.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has increased from 0.97 (Mar 24) to 1.33, marking an increase of 0.36.
- For Retention Ratios (%), as of Mar 25, the value is 94.28. This value exceeds the healthy maximum of 70. It has increased from 91.30 (Mar 24) to 94.28, marking an increase of 2.98.
- For Price / BV (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. It has decreased from 1.05 (Mar 24) to 0.92, marking a decrease of 0.13.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has increased from 0.97 (Mar 24) to 1.33, marking an increase of 0.36.
- For EarningsYield, as of Mar 25, the value is 0.10. This value is below the healthy minimum of 5. It has increased from 0.09 (Mar 24) to 0.10, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sree Rayalaseema Hi-Strength Hypo Ltd:
- Net Profit Margin: 13.71%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.35% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.8% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 46.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 8.38
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 9.19 (Industry average Stock P/E: 172.09)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 13.71%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | Gondiparla, Kurnool Andhra Pradesh 518004 | srhypo@tgvmail.net http://www.tgvgroup.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. T G Shilpa Bharath | Chairperson & Managing Director |
| Mr. H Gurunath Reddy | Non Executive Director |
| Mr. Satyam Gadwal | Non Executive Director |
| Mr. A Kailashnath | Independent Director |
| Mr. Kamma Edlapalli Krishna | Independent Director |
| Mrs. R Triveni | Independent Woman Director |
FAQ
What is the intrinsic value of Sree Rayalaseema Hi-Strength Hypo Ltd?
Sree Rayalaseema Hi-Strength Hypo Ltd's intrinsic value (as of 19 November 2025) is 478.19 which is 10.28% lower the current market price of 533.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 919 Cr. market cap, FY2025-2026 high/low of 870/464, reserves of ₹905 Cr, and liabilities of 1,059 Cr.
What is the Market Cap of Sree Rayalaseema Hi-Strength Hypo Ltd?
The Market Cap of Sree Rayalaseema Hi-Strength Hypo Ltd is 919 Cr..
What is the current Stock Price of Sree Rayalaseema Hi-Strength Hypo Ltd as on 19 November 2025?
The current stock price of Sree Rayalaseema Hi-Strength Hypo Ltd as on 19 November 2025 is 533.
What is the High / Low of Sree Rayalaseema Hi-Strength Hypo Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sree Rayalaseema Hi-Strength Hypo Ltd stocks is 870/464.
What is the Stock P/E of Sree Rayalaseema Hi-Strength Hypo Ltd?
The Stock P/E of Sree Rayalaseema Hi-Strength Hypo Ltd is 9.19.
What is the Book Value of Sree Rayalaseema Hi-Strength Hypo Ltd?
The Book Value of Sree Rayalaseema Hi-Strength Hypo Ltd is 588.
What is the Dividend Yield of Sree Rayalaseema Hi-Strength Hypo Ltd?
The Dividend Yield of Sree Rayalaseema Hi-Strength Hypo Ltd is 0.56 %.
What is the ROCE of Sree Rayalaseema Hi-Strength Hypo Ltd?
The ROCE of Sree Rayalaseema Hi-Strength Hypo Ltd is 14.9 %.
What is the ROE of Sree Rayalaseema Hi-Strength Hypo Ltd?
The ROE of Sree Rayalaseema Hi-Strength Hypo Ltd is 11.0 %.
What is the Face Value of Sree Rayalaseema Hi-Strength Hypo Ltd?
The Face Value of Sree Rayalaseema Hi-Strength Hypo Ltd is 10.0.